Clinical trial
Assessment of Tyrosine Kinase Inhibitors on Thyroid Functions in Patients With Chronic Myeloid Leukemia
NCT07200882 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Tyrosine Kinase Inhibitors on Thyroid Functions in Patients With Chronic Myeloid Leukemia
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 1, 2025
- Completion date
- December 1, 2027
- Enrollment
- 76 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
leukaemia (chronic)